Viyash Scientific Limited (NSE:VIYASH)

Market Cap	97.67B +139.7%
Revenue (ttm)	18.17B +20.3%
Net Income	975.88M +737.6%
EPS	3.82 +731.4%
Shares Out	n/a
PE Ratio	100.08
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	155,197
Average Volume	691,017
Open	224.21
Previous Close	223.97
Day's Range	219.20 - 224.21
52-Week Range	117.35 - 257.85
Beta	n/a
RSI	60.52
Earnings Date	Feb 5, 2026

About Viyash Scientific

Viyash Scientific Limited operates in the veterinary healthcare business in Europe, Asia, and internationally. The company provides finished dosage formulation in therapeutic areas, such as nutrition, pain management, parasite control, antibiotics, and gut health for livestock, poultry, and companion animals. It also offers analytical services; and VET formulation services. The company was formerly known as Sequent Scientific Limited and changed its name to Viyash Scientific Limited in January 2026. The company was incorporated in 1985 and is h...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1985
• Employees: 1,244
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: VIYASH